These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8812840

  • 1. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
    McDonald JR, Ong M, Shen C, Parandoosh Z, Sosnowski B, Bussell S, Houston LL.
    Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
    [Abstract] [Full Text] [Related]

  • 2. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
    Lappi DA, Maher PA, Martineau D, Baird A.
    J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
    Beitz JG, Davol P, Clark JW, Kato J, Medina M, Frackelton AR, Lappi DA, Baird A, Calabresi P.
    Cancer Res; 1992 Jan 01; 52(1):227-30. PubMed ID: 1309225
    [Abstract] [Full Text] [Related]

  • 4. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin.
    Lappi DA, Matsunami R, Martineau D, Baird A.
    Anal Biochem; 1993 Aug 01; 212(2):446-51. PubMed ID: 8214586
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C, Li J, Micko CJ, Pierce GF, Cunningham MR, Lumsden AB.
    J Surg Res; 1998 Feb 15; 75(1):35-41. PubMed ID: 9614854
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High-level expression and purification of biologically active recombinant pokeweed antiviral protein.
    Rajamohan F, Engstrom CR, Denton TJ, Engen LA, Kourinov I, Uckun FM.
    Protein Expr Purif; 1999 Jul 15; 16(2):359-68. PubMed ID: 10419833
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
    Buechler YJ, Sosnowski BA, Victor KD, Parandoosh Z, Bussell SJ, Shen C, Ryder M, Houston LL.
    Eur J Biochem; 1995 Dec 15; 234(3):706-13. PubMed ID: 8575426
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intein-mediated fusion expression, high efficient refolding, and one-step purification of gelonin toxin.
    Guo C, Li Z, Shi Y, Xu M, Wise JG, Trommer WE, Yuan J.
    Protein Expr Purif; 2004 Oct 15; 37(2):361-7. PubMed ID: 15358358
    [Abstract] [Full Text] [Related]

  • 13. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
    Lappi DA, Ying W, Barthelemy I, Martineau D, Prieto I, Benatti L, Soria M, Baird A.
    J Biol Chem; 1994 Apr 29; 269(17):12552-8. PubMed ID: 8175664
    [Abstract] [Full Text] [Related]

  • 14. Biological and chemical characterization of basic FGF-saporin mitotoxin.
    Lappi DA, Martineau D, Baird A.
    Biochem Biophys Res Commun; 1989 Apr 28; 160(2):917-23. PubMed ID: 2541718
    [Abstract] [Full Text] [Related]

  • 15. Expression and characterization of a basic fibroblast growth factor-saporin fusion protein in Escherichia coli.
    Prieto I, Lappi DA, Ong M, Matsunami R, Benatti L, Villares R, Soria M, Sarmientos P, Baird A.
    Ann N Y Acad Sci; 1991 Apr 28; 638():434-7. PubMed ID: 1785817
    [No Abstract] [Full Text] [Related]

  • 16. Non-fusion expression in Escherichia coli, purification, and characterization of a novel Ca2+- and phospholipid-binding protein annexin B1.
    Zhang Y, Guo YJ, Sun SH, Yan HL, He Y.
    Protein Expr Purif; 2004 Mar 28; 34(1):68-74. PubMed ID: 14766301
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Local infusion of FGF-saporin reduces intimal hyperplasia.
    Mattar SG, Hanson SR, Pierce GF, Chen C, Hughes JD, Cook JE, Shen C, Noe BA, Suwyn CR, Scott JR, Lumsden AB.
    J Surg Res; 1996 Feb 01; 60(2):339-44. PubMed ID: 8598665
    [Abstract] [Full Text] [Related]

  • 20. P1GF-saporin fusion protein: a potential anti-angiogenic agent.
    Chiaramonte R, Polizzi D, Bartolini E, Petroni D, Comi P.
    Anticancer Drug Des; 1997 Dec 01; 12(8):649-57. PubMed ID: 9448704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.